Longitudinal studies have demonstrated gradual declines of serum concentration of inflammatory biomarkers including IL-6, IL-8, tumor necrosis factor-α, and high-sensitivity C-reactive protein (hs-CRP) at the late stage of illness in COVID-19 survivors (29). The gene discussed is CRP; the disease is COVID-19.